An editorial in a leading medical journal argues that society loses when drugmakers make too many medicines that treat illness in nearly the same way. The authors suggest a higher standard for approval of new brand-name drugs once a a cheap generic in
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/02/15/133784085/should-fda-hold-me-too-drugs-to-a-higher-standard?ft=1&f=103537970
Posted
Feb 15 2011, 02:25 PM
by
NPR Blogs: Shots - Health Blog